Ufp Technologies (UFPT) Cash & Current Investments (2010 - 2026)
Ufp Technologies (UFPT) posted Cash & Current Investments of $20.0 million for Q1 2026, down 1.6% on a QoQ basis from $20.3 million in Q4 2025, and up 42.4% year-over-year from $14.0 million in Q1 2025.
Ufp Technologies (UFPT) Cash & Current Investments (2010 - 2026) Analysis & Trends
Ufp Technologies' Cash & Current Investments history runs 17 years deep, the most recent figure standing at $20.0 million for Q1 2026.
- Quarterly Cash & Current Investments rose 42.4% year-over-year to $20.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.0 million (up 42.4% YoY) and the FY2025 annual result came in at $20.3 million, up 50.94% from the prior year.
- Cash & Current Investments was $20.0 million for Q1 2026 at Ufp Technologies, down from $20.3 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $20.3 million in Q4 2025 and bottomed at $3.7 million in Q1 2022.
- A 5-year average of $11.7 million and a median of $12.4 million in 2024 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments plunged 85.61% — and 2024, when it soared 216.16%.
- Ufp Technologies' Cash & Current Investments stood at $4.5 million in 2022, then surged by 43.25% to $6.4 million in 2023, then soared by 110.95% to $13.4 million in 2024, then soared by 50.94% to $20.3 million in 2025, then fell by 1.6% to $20.0 million in 2026.
- Business Quant data shows UFPT's Cash & Current Investments at $20.0 million in Q1 2026, $20.3 million in Q4 2025, and $18.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Ufp Technologies | 1.90 Bn | 1.88 Bn | 44.36 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.98 Mn |
| Dec 31, 2025 | 20.30 Mn |
| Sep 30, 2025 | 18.23 Mn |
| Jun 30, 2025 | 14.89 Mn |
| Mar 31, 2025 | 14.03 Mn |
| Dec 31, 2024 | 13.45 Mn |
| Sep 30, 2024 | 16.36 Mn |
| Jun 30, 2024 | 16.73 Mn |
| Mar 31, 2024 | 11.37 Mn |
| Sep 30, 2023 | 6.38 Mn |
| Jun 30, 2023 | 5.29 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Dec 31, 2022 | 4.45 Mn |
| Sep 30, 2022 | 9.94 Mn |
| Jun 30, 2022 | 5.58 Mn |
| Mar 31, 2022 | 3.65 Mn |
| Sep 30, 2021 | 33.09 Mn |
| Jun 30, 2021 | 30.27 Mn |
| Mar 31, 2021 | 25.38 Mn |
| Sep 30, 2020 | 17.44 Mn |